Immunotherapy Cost in India

The cost of immunotherapy in India can vary depending on the type of treatment and the severity of the cancer. However, immunotherapy is generally more affordable than other types of cancer treatment, such as chemotherapy and radiation therapy. The average cost of immunotherapy in India is around Rs. 1,50,000- 4,50,000.

Dr. Saphalta is one of the leading cancer treatment centers in India, offering the latest treatments and technologies for cancer patients. Contact us today to learn more about our affordable immunotherapy services.

However, the costs can differ depending on various factors that play a major role in deciding the immunotherapy cost in India.

In India, immunotherapy is highly affordable and economical.

The cost mainly depends on the drugs used for the treatment, duration of the treatment, pre-treatment tests, expertise of the oncologist providing the treatment, and the medications to manage the side effects or other health concerns of the patient. Among these, the type of drug used, which depends on the type of cancer and the method of immunotherapy opted for, is the main determiner of the cost.

Dr. Saphalta Baghmar provides cost-effective immunotherapy treatment in India. With her specialization in this treatment, she ensures that her patients get the appropriate treatment needed for their efficient recovery.

Dr. Saphalta Baghmar, the best oncologist in India offers the latest treatments and technologies for cancer patients. Contact us today to learn more about our affordable immunotherapy services.

Immunotherapy costs in India can vary depending on factors such as the type of treatment, the severity of the cancer, and the medications used. However, it is generally more affordable than other cancer treatments like chemotherapy and radiation therapy. On average, immunotherapy cost in India ranges from Rs. 1,50,000 to 4,50,000.

Several factors influence the overall cost, including the drugs used, the duration of the treatment, pre-treatment tests, and the oncologist's expertise. The primary factor determining the cost is the type of drug, which depends on the type of cancer and the chosen immunotherapy method.

Dr. Saphalta Baghmar, the best oncologist in Faridabad, offers advanced and cost-effective immunotherapy treatments, ensuring her patients receive personalized care for their recovery. With her vast expertise, she utilizes the latest technologies and approaches in cancer care. For a more accurate cost range, talk with Dr. Saphalta Baghmar today.

Immunotherapy Cost In India

Type of Immunotherapy	Cost Range (INR)	Comments
Checkpoint Inhibitors	2500- 1 .5 lacs	Per cycle; commonly used for cancers like melanoma.
CAR T-Cell Therapy	₹30,00,000 - ₹60,00,000	Cost varies based on the type of cancer.
Monoclonal Antibodies	₹1,50,000 - ₹4,00,000	Per cycle; used in various cancers.
Cancer Vaccines	₹50,000 - ₹2,00,000	Depends on the type of vaccine.
Adoptive Cell Transfer	₹3,00,000 - ₹7,00,000	Personalized treatment costs can vary.
Cytokines	₹50,000 - ₹2,00,000	Costs per dose; varies by cancer type.
Immunomodulators	₹1,00,000 - ₹3,00,000	Often used in combination with other therapies.
Targeted Antibodies	₹1,50,000 - ₹5,00,000	Cost depends on the specific target and cancer type.

Notes:

• Costs can vary based on the hospital, city, and the specific medical condition.
• Additional costs may include diagnostic tests, hospital stay, and consultation fees.
• Insurance coverage can significantly impact out-of-pocket expenses.

Related Blog Immunotherapy vs Chemotherapy: Which Treatment is Better?

Listed below are all the pre-treatment costs you might have to incur before undergoing immunotherapy:

Before we discuss the actual immunotherapy cost, let's first look at all pre-treatment expenses.

• The consultation fee: You will first have to visit a cancer specialist for a consultation. The specialist will evaluate your case and recommend the best course of treatment. The consultation fee can range from Rs. 500- 5,000 depending on the doctor and the hospital.
• Imaging tests: Once the doctor has recommended immunotherapy, you will need to undergo some imaging tests to check the severity and stage of the cancer. These tests can include a CT scan, MRI, or PET scan. The cost of these tests can range from Rs. 5,000- 40,000 depending on the hospital and the type of test.
• Biopsy: A biopsy is a procedure where a small sample of tissue is taken from the cancerous area for further testing. The cost of a biopsy can range from Rs. 20,000- 30,000 depending on the hospital and the type of biopsy.
• Blood tests: You will also need to undergo some blood tests to check your overall health and to see if you are a good candidate for immunotherapy. The cost of these tests can range from Rs. 1,000- 5,000 depending on the hospital and the type of test.
• Other pretreatment costs: There are other miscellaneous pre-treatment costs that you might have to incur, such as the cost of medications, travel, and accommodation. These costs can vary depending on the individual case.
• Extra Medication cost: After receiving immunotherapy, you may suffer from some side – effects. To minimize the side – effects, you may be given extra medications. This will add up to your cost of immunotherapy.

Note: The number of sessions required will depend on the severity of the cancer. Some patients may require only one session, while others may require multiple sessions.

How does Immunotherapy work?

How does immunotherapy enhance the ability of your immune system? It does so by one of these five means.

Monoclonal Antibodies

This method introduces a group of antibodies to your body that specifically binds to the cancerous cells and alerts your immune system.

Adoptive Cell Therapy

Also called T-cell transfer therapy, this method enhances the performance of your body's T-cells.

Checkpoint Inhibition

This method blocks the immunity checkpoints that prevent your body from eliciting a strong immune response.

Treatment Vaccines

These work similarly to normal vaccines and enhance your body's immune response.

Immune System Modifiers

These drugs work on certain aspects of your immune system, allowing for an overall strong immune response.

Various factors play a major role in deciding the immunotherapy cost in India

• The type of immunotherapy treatment required
• The severity of the cancer
• The stage of the cancer
• The size of the cancer
• The location of the cancer
• The type of cancer
• The age of the patient
• The overall health of the patient

Any complex cancer treatment, including immunotherapy, requires the expertise of a specialized cancer department.

Related BlogNutrition And Cancer: How A Healthy Diet Can Support Different Stages Of Cancer

Factors Affecting Cost Of Immunotherapy in India

By using the body's immune system to identify and eliminate cancer cells, immunotherapy has completely transformed the way cancer is treated. Immunotherapy can provide more targeted activity with possibly fewer adverse effects than conventional treatments like radiation and chemotherapy. However, the high expense of immunotherapy is one of the main issues that patients and caregivers deal with. Costs still differ greatly in India, a nation renowned for its reasonably priced healthcare when compared to Western countries. 

Patients can better plan their course of treatment and make educated decisions by being aware of the variables that affect these expenses.

The main factors influencing immunotherapy costs in India are deeply examined in this article, ranging from medication costs and treatment regimens to hospital facilities and support services:-

1. Immunotherapy Type: Immunotherapy is a wide term that encompasses various methods. Every variety has a distinct cost profile. For eg:-

• Monoclonal antibodies are proteins produced in a lab that target particular indicators of cancer cells. Examples include nivolumab and pembrolizumab, which are generally costly because of complex production procedures.
• Checkpoint inhibitors. Because they are more recent and patented, they frequently fetch premium prices.
• One of the most sophisticated and customized immunotherapies is CAR-T cell therapy, which entails removing a patient's T cells, modifying them, and then reintroducing them. It may be one of the more expensive solutions due to this highly customized approach.
• Although they are typically less expensive than CAR-T, cancer vaccines and cytokines can still be pricey depending on the particular treatment and frequency.

Cost is directly impacted by the varying degrees of research, manufacturing investment, and clinical application associated with each class of immunotherapy.

2. Patents and Drug Prices: The cost of the immunotherapy medications themselves is one of the biggest expense factors. Since many of these treatments are created by large pharmaceutical corporations and are patent-protected, generic competition is constrained. Patients in India frequently depend on imported medications priced in foreign markets in the absence of locally available generic drugs, which raises expenses due to taxes and import tariffs, changes in currency exchange rates, and affordable alternatives are restricted by patent protection.

Even though local generic medication has increased in India, many patients still have to pay high drug-related costs because acceptance and regulatory clearances take time.

3. Medical Facility and Hospital: The total cost is greatly impacted by the hospital or cancer care facility selected. Due to their more sophisticated facilities and higher operating expenses, private tertiary care institutions typically charge more for immunotherapy. Although public and government-aided hospitals are less expensive, waiting times and accessibility may differ.

Oncology-focused facilities, especially those with specialized immunotherapy treatments, may charge more because of their skilled staff, advanced monitoring tools, and interdisciplinary care. Higher treatment costs are inevitable for hospitals with advanced diagnostic equipment, individualized care plans, and close observation.

4. Duration and Protocol of Treatment: Immunotherapy is rarely a one-size-fits-all strategy; instead, treatment plans are customized according to patient response, cancer type, stage, and general health. Cost-influencing factors include the number of cycles required,many protocols increase the overall cost of treatment by combining immunotherapy with targeted medicines, chemotherapy, or radiation. The total cost increases with the intensity or duration of the regimen.

5. Location: In India, the cost of healthcare varies greatly by region and city. Due to increased living and operating costs, treatment charges are usually greater in metropolitan areas like Bangalore, Delhi, and Mumbai.

Although tier-2 and tier-3 cities could be less expensive, they might not have as much access to specialized oncologists and the newest immunotherapy alternatives. Patients frequently weigh access to expertise against cost, which may influence the treatment institution and city they choose.

6. Tests for Diagnosis and Monitoring: To ensure efficacy and patient safety, immunotherapy necessitates thorough diagnostic testing and monitoring. To identify appropriate candidates for particular immunotherapies, genetic and biomarker testing PET, CT, and MRI imaging examinations to evaluate tumor response. Frequent blood tests to track immunological response and identify adverse effects. Despite being essential for the best possible results, these ancillary tests raise the overall cost of care considerably.

7. Adverse effects and Supportive Care: Although immunotherapy is typically more well tolerated than conventional chemotherapy, it can nonetheless have adverse effects like:

Adverse effects associated with the immune system (such as skin rashes, exhaustion, and endocrine problems) inflammatory responses that necessitate hospitalization or medication. Additional medications, expert consultations, and supportive care are frequently needed to manage side effects, which raises the total cost of treatment.

Patients and caregivers are more prepared to make treatment decisions, look into financial aid options, and make reasonable care plans when they are aware of these concerns. It is anticipated that immunotherapy will become more widely available and affordable as India continues to increase its production of biosimilars and enhance healthcare access, guaranteeing that everyone who needs life-saving medicines may obtain them.

Cost of Immunotherapy for bladder cancer in India and medical cost

In India, immunotherapy is given to patients with advanced bladder cancer who are ineligible for cisplatin chemotherapy as a first-line treatment. Immunotherapy improves bladder cancer outcomes and reduces recurrence risk. Furthermore, it improves the patient's survival rate. As the first approved immunotherapy, BCG stimulates the immune system, which targets bacteria and bladder cancer cells nearby.

The cost of drugs immunotherapy in India for bladder cancer is:

Dr. Saphalta Baghmar and her team provide customized breast cancer treatment in India to patients. Their treatment method involves a combination of two or more of the following methods:

• BCG- Rs. 1,500 per vial
• Pembrolizumab- Rs. 2,00,000 to 4,00,000 per vial
• Atezolizumab- Rs. 2,25,000 per vial
• Nivolumab- Rs. 2,00,000 to 2,50,000 per vial
• Cabozantinib- Rs. 2,70,000 per vial
• Ipsen Biopharmaceuticals Inc.- Rs. 8,00,000
• Merck & Co., Inc.- Rs. 2,50,000

Cost of Immunotherapy for breast cancer in India and medical cost

Women are most likely to develop breast cancer and suffer most from this disease. In India, atezolizumab (Tecentriq) was approved as the first immunotherapy drug for triple-negative breast cancer.

Some immunotherapy drugs have shown excellent results in breast cancer clinical trials.

Immunotherapy for cervical cancer

The second most common cancer in women in India is cervical cancer. Infection with HPV (human papillomavirus) is associated with most cervical cancer cases. To prevent cervical cancer, HPV vaccines are given to prevent infection by HPV.

Why choose Dr. Saphalta for the best & affordable immunotherapy treatment in India?

• Dr. Saphalta is a leading oncologist in India with over 11 years of experience in treating cancer patients.
• She specializes in immunotherapy and has been using this treatment modality for the past 11 years.
• She has treated hundreds of cancer patients with immunotherapy and has seen excellent results.
• She offers affordable immunotherapy treatment packages that are much cheaper than other hospitals in India.

So, book a consultation today with Dr. Saphalta and get the best immunotherapy treatment in Indiaat an affordable price.

FAQ

1. What is the cost of immunotherapy in India?

The cost of immunotherapy in India varies based on the frequency of the treatment, the drugs used, the overall treatment plan, and the health status of the patient. Consult with your cancer care team about the estimated duration of the treatment and the approximate cost.

Usually, cancer treatment involves a combination of different methods, and the cost may be estimated as a whole. Talking about the estimated cost before starting the treatment would give you a better idea.

2. Which immunotherapy drugs are approved in India?

Drugs like Nivolumumab, Pembrolizumab, Durvalumab and Atezolizumab are approved and frequently used for immunotherapy treatment in India. These drugs are employed in the treatment of lung cancer, head and neck cancer, liver cancer, kidney cancer, Hodgkin's lymphoma, urinary bladder cancer, and malignant melanoma.

The drug is chosen based on the type and stage of cancer and the patient’s response to it. Consult with your doctor to discuss the type of drug used, its associated benefits, and the potential side effects.

3. Who cannot use immunotherapy?

Immunotherapy is generally safe for a large part of the population as a cancer treatment method. However, people with immune system disorders or autoimmune diseases may need to avoid this treatment. Such conditions may include lupus, Crohn’s disease, rheumatoid arthritis, myasthenia gravis, and multiple sclerosis.

Inform your doctor about your current health status and your medical history before devising a treatment plan. This allows them to assess your case and determine your eligibility for different cancer treatment methods.

4. Is immunotherapy better than chemo?

Immunotherapy has advantages and disadvantages over chemotherapy. While immunotherapy primarily targets and attacks cancerous cells, chemotherapy has a greater risk of causing harm to healthy cells. Consequently, the side effects of immunotherapy are fewer and less severe than those of chemotherapy. However, the effect of chemotherapy is immediate, as it shrinks and kills the tumour cells in a short time, whereas immunotherapy takes longer to show its effect. Therefore, the type and stage of cancer and the patient’s overall health must be taken into consideration before deciding on the primary treatment method in a patient’s cancer treatment plan.

5. What is the success rate of immunotherapy in India?

The success rate of immunotherapy in India is estimated to be between 20% and 40%.The individual success rate of immunotherapy for a patient depends on the type and stage of cancer and the person's health status.

Consult with an expert oncologist experienced in immunotherapy treatment to determine if it will be a favorable part of your treatment plan.